Hypogammaglobulinemia at leukapheresis predicts delayed humoral immune reconstitution and increased risk of infections after CD19 CAR-T for B-cell lymphoma
{{output}}
Background: Infectious complications account for approximately half of non-relapse mortality after chimeric antigen receptor T cell (CAR-T) therapy, yet the impact of pre-infusion humoral immunity on post-infusion immune reconsti... ...
